UBS Group
ALVOW icon

UBS Group’s Alvotech Warrant ALVOW Stock Holding History

UBS Group’s Portfolio ALVOW Stock Details ALVOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71 Sell
373
-199
-35% -$79 ﹤0.01% 10163
2025
Q4 		$372 Buy
572
+546
+2,100% +$591 ﹤0.01% 9997
2025
Q3 		$39 Sell
26
-2,647
-99% -$3.76K ﹤0.01% 10049
2025
Q2 		$3.56K Buy
2,673
+1,123
+72% +$1.99K ﹤0.01% 9339
2025
Q1 		$2.34K Buy
+1,550
New +$3.78K ﹤0.01% 9355
2024
Q4 		– Sell
-64
Closed -$173 – 9888
2024
Q3 		$173 Sell
64
-12
-16% -$33 ﹤0.01% 9092
2024
Q2 		$227 Hold
76
– – ﹤0.01% 9059
2024
Q1 		$251 Buy
+76
New +$290 ﹤0.01% 8683
2023
Q4 		– Sell
-128
Closed -$179 – 9260
2023
Q3 		$179 Buy
+128
New +$211 ﹤0.01% 8740
2023
Q2 		– Sell
-200
Closed -$474 – 8854
2023
Q1 		$474 Buy
200
+191
+2,122% +$382 ﹤0.01% 9017
2022
Q4 		$8 Sell
9
-6,336
-100% -$4.39K ﹤0.01% 10595
2022
Q3 		$4K Buy
6,345
+1,781
+39% +$1.29K ﹤0.01% 9324
2022
Q2 		$4K Buy
+4,564
New +$4.13K ﹤0.01% 9028

Other funds holding ALVOW

OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

UBS Group's ALVOW Position: Q1 2026 in Review

UBS Group reduced its Alvotech Warrant (ALVOW) stake by 35% in Q1 2026, selling an estimated $79 and leaving 373 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #10163.

UBS Group first reported a position in ALVOW in Q2 2022 and has held it in 13 quarters since. The position peaked at $4K in Q3 2022. 6 funds tracked by Wall St. Rank hold ALVOW as of Q1 2026.

  • UBS Group held 373 shares of Alvotech Warrant worth $71 as of Q1 2026.
  • UBS Group sold 199 Alvotech Warrant shares in Q1 2026, an estimated $79.
  • Alvotech Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10163 holding.
  • UBS Group first reported a position in Alvotech Warrant in Q2 2022 and has held it in 13 quarters since.
  • UBS Group's Alvotech Warrant position peaked at $4K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Alvotech Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.